Skip to main content

News and Media

Open Main MenuClose Main Menu

OSU-CHS researcher studying if weight loss drugs could be used to treat alcohol use disorder

Semaglutide, the medication in the popular diabetes and weight loss drugs Ozempic and Wegovy, continues making headlines. What if it could also help curb substance use disorder or addiction?
Kyle Simmons, Ph.D., Professor of Pharmacology and Physiology at OSU Center for Health Sciences, is leading the Semaglutide Therapy for Alcohol Reduction (STAR) study in Tulsa.
Back To Top
SVG directory not found.